These emerging medications , including Semaglutide , belong to a category of drugs called GLP-1 receptor agonists . Initially intended for controlling type 2 diabetes , they function by encouraging the pancreas to produce adequate insulin and limiting excessive blood sugar levels. Furthermore , their ability to support weight management has led to